首页> 外国专利> Use of trastuzumab for the Prevention or reduction of metastasis in a patient suffering from Cancer HER2 positive,That does not respond to monotherapy with trastuzumab and pertuzumab monotherapy with.

Use of trastuzumab for the Prevention or reduction of metastasis in a patient suffering from Cancer HER2 positive,That does not respond to monotherapy with trastuzumab and pertuzumab monotherapy with.

机译：曲妥珠单抗用于预防或减少癌症HER2阳性患者的转移，对曲妥珠单抗和培妥珠单抗的单药治疗无效。

页面导航

摘要
著录项
相似文献

摘要

Use of trastuzumab for the Prevention or reduction of metastasis in a patient suffering from Cancer HER2 positive,That does not respond to monotherapy with trastuzumab and pertuzumab monotherapy with.

机译：曲妥珠单抗用于预防或减少癌症HER2阳性患者的转移，对曲妥珠单抗和培妥珠单抗的单药治疗无效。

著录项

公开/公告号CL2007002667A1

专利类型
公开/公告日2008-01-25

原文格式PDF
申请/专利权人 F. HOFFMANN-LA ROCHE AG.;
展开▼

申请/专利号CL20070002667
发明设计人 FRIESS THOMAS;HASMANN MAX;SCHEUER WERNER.;
展开▼

申请日2007-09-13
分类号A61K39/395;A61P35/00;A61P35/04;C07K16/32;
国家 CL
入库时间 2022-08-21 20:08:33

相似文献

专利
外文文献
中文文献